Société Immune Pharmaceuticals Inc OTC Bulletin Board
Actions
IMNP
US45254C1018
Produits pharmaceutiques
Cours en clôture
Autres places de cotation
|
||
- USD | - |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 37 | 12/04/21 | |
Devin J. Shaw
DFI | Director of Finance/CFO | 37 | 13/04/21 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 11/12/17 |
Tony Fiorino
BRD | Director/Board Member | 56 | 15/08/17 |
Boris Shor
PRN | Corporate Officer/Principal | - | - |
John P. Clark
AUD | Comptroller/Controller/Auditor | 52 | 20/11/17 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | - |
Tony Fiorino
BRD | Director/Board Member | 56 | 15/08/17 |
John A. Neczesny
BRD | Director/Board Member | 60 | 02/02/16 |
Daniel Kazado
BRD | Director/Board Member | 59 | 10/10/13 |
Jeff Paley
BRD | Director/Board Member | 55 | 23/02/16 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 3 713 | 0 | 0 | 100,00 % |
Action B | 1 | 172 878 093 | 172 878 093 ( 100,00 %) | 0 |
Coordonnées société
Immune Pharmaceuticals, Inc.
1 Bridge Plaza North Suite 270
07024, Englewood Cliffs
+201-464-2677
http://www.immunepharma.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+29,98% | 682 Md | |
+31,46% | 586 Md | |
-3,52% | 364 Md | |
+18,59% | 327 Md | |
+4,07% | 285 Md | |
+16,43% | 240 Md | |
+9,34% | 209 Md | |
-9,20% | 203 Md | |
+7,09% | 165 Md |
- Bourse
- Actions
- Action FZRQ
- Action IMNP
- Société Immune Pharmaceuticals Inc